136
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Cubosome-based thermosensitive in situ gelling system for intranasal administration of lamotrigine with enhanced antiepileptic efficacy

ORCID Icon, ORCID Icon & ORCID Icon
Pages 520-534 | Received 21 Feb 2023, Accepted 18 May 2023, Published online: 25 May 2023

References

  • Abdelmonem R, Azer MS, Makky A, Zaghloul A, El-Nabarawi M, Nada A. 2020. Development, characterization, and in-vivo pharmacokinetic study of lamotrigine solid self-nanoemulsifying drug delivery system. Drug Des Devel Ther. 14:4343–4362.
  • Abdelrahman FE, Elsayed I, Gad MK, Badr A, Mohamed MI. 2015. Investigating the cubosomal ability for transnasal brain targeting: in vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 490(1-2):281–291.
  • Aboud HM, El Komy MH, Ali AA, El Menshawe SF, Abd Elbary A. 2016. Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery. AAPS PharmSciTech. 17(6):1353–1365.
  • Abourehab MA, Ansari MJ, Singh A, Hassan A, Abdelgawad MA, Shrivastav P, Abualsoud BM, Amaral LS, Pramanik S. 2022. Cubosomes as an emerging platform for drug delivery: a state-of-the-art review. J Mater Chem B. 10(15):2781–2819.
  • Aditya N, Shim M, Lee I, Lee Y, Im M-H, Ko S. 2013. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity. J Agric Food Chem. 61(8):1878–1883.
  • Aeby A, Ceulemans B, Lagae L. 2022. Treatment of focal-onset seizures in children: should this be more etiology-driven? Front Neurol. 13:842276.
  • Ahirrao M, Shrotriya S. 2017. In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. Drug Dev Ind Pharm. 43(10):1686–1693.
  • Ahmad S, Fowler L, Leach M, Whitton P. 1995. Lamotrigine alters veratridine-but not K+-evoked amino acid release in the ventral hippocampus of the rat in vivo. Br J Pharmacol. 115:116–116.
  • Akyuz E, Polat AK, Eroglu E, Kullu I, Angelopoulou E, Paudel YN. 2021. Revisiting the role of neurotransmitters in epilepsy: an updated review. Life Sci. 265:118826.
  • Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y. 2015. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv. 12(2):181–194.
  • Alese OO, Mabandla MV. 2019. Upregulation of hippocampal synaptophysin, GFAP and mGluR3 in a pilocarpine rat model of epilepsy with history of prolonged febrile seizure. J Chem Neuroanat. 100:101659.
  • Arisoy S, Sayiner O, Comoglu T, Onal D, Atalay O, Pehlivanoglu B. 2020. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery. Pharm Dev Technol. 25(6):735–747.
  • Arora T, Mehta AK, Sharma KK, Mediratta PK, Banerjee BD, Garg GR, Sharma AK. 2010. Effect of carbamazepine and lamotrigine on cognitive function and oxidative stress in brain during chemical epileptogenesis in rats. Basic Clin Pharmacol Toxicol. 106(5):372–377.
  • Asfour MH, Abd El-Alim SH, Awad GEA, Kassem AA. 2021. Chitosan/beta-glycerophosphate in situ forming thermo-sensitive hydrogel for improved ocular delivery of moxifloxacin hydrochloride. Eur J Pharm Sci. 167:106041.
  • Asfour MH, Salama AAA, Mohsen AM. 2021. Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats. J Pharm Sci. 110(9):3208–3220.
  • Azhari H, Strauss M, Hook S, Boyd BJ, Rizwan SB. 2016. Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier. Eur J Pharm Biopharm. 104:148–155.
  • Barauskas J, Misiunas A, Gunnarsson T, Tiberg F, Johnsson M. 2006. “Sponge” Nanoparticle Dispersions in Aqueous Mixtures of Diglycerol Monooleate, Glycerol Dioleate, and Polysorbate 80. Langmuir. 22(14):6328–6334.
  • Barriga HM, Holme MN, Stevens MM. 2019. Cubosomes: the next generation of smart lipid nanoparticles? Angew Chem Int Ed Engl. 58(10):2958–2978.
  • Benamer HT, Grosset DG. 2009. A systematic review of the epidemiology of epilepsy in Arab countries. Epilepsia. 50(10):2301–2304.
  • Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E. 2012. The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist. 18(5):467–486.
  • Betchel NT, Fariba Ka AS. 2023. Lamotrigine. Treasure Island (FLorida): StatPearls; https://www.ncbi.nlm.nih.gov/books/NBK470442/
  • Betzer O, Shilo M, Opochinsky R, Barnoy E, Motiei M, Okun E, Yadid G, Popovtzer R. 2017. The effect of nanoparticle size on the ability to cross the blood–brain barrier: an in vivo study. Nanomedicine (Lond). 12(13):1533–1546.
  • Bhatt M, Bhatt GK. 2017. An overview: formulation and product development of nasal spray. World J Pharm Res. 6:404–413.
  • Bozzi Y, Borrelli E. 2013. The role of dopamine signaling in epileptogenesis. Front Cell Neurosci. 7:157.
  • Choi Y-S, Jun I-G, Kim S-H, Park J-Y. 2013. Intrathecal lamotrigine attenuates mechanical allodynia and suppresses microglial and astrocytic activation in a rat model of spinal nerve ligation. Yonsei Med J. 54(2):321–329.
  • Choi H-G, Oh Y-K, Kim C-K. 1998. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. Int J Pharm. 165(1):23–32.
  • Choi J-Y, Park CH, Lee J. 2008. Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Deliv. 15(5):347–353.
  • Chong JY, Mulet X, Waddington LJ, Boyd BJ, Drummond CJ. 2012. High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. Langmuir. 28(25):9223–9232.
  • Colombo G, Lorenzini L, Zironi E, Galligioni V, Sonvico F, Balducci AG, Pagliuca G, Giuliani A, Calzà L, Scagliarini A. 2011. Brain distribution of ribavirin after intranasal administration. Antiviral Res. 92(3):408–414.
  • Devkar TB, Tekade AR, Khandelwal KR. 2014. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer. Colloids Surf B Biointerfaces. 122:143–150.
  • do Canto AM, Donatti A, Geraldis JC, Godoi AB, da Rosa DC, Lopes-Cendes I. 2020. Neuroproteomics in epilepsy: what do we know so far? Front Mol Neurosci. 13:604158.
  • Eldeeb AE, Salah S, Ghorab M. 2019. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 52:236–247.
  • EL-Hadi AA, Ahmed HM, Zaki RA, Mohsen AM. 2020. Enhanced enzymatic activity of streptomyces griseoplanus L-asparginase via its incorporation in an oil based nanocarrier. Int J App Pharm. 12(5):203–210.
  • Elnaggar YS, Etman SM, Abdelmonsif DA, Abdallah OY. 2015. Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer’s disease: pharmaceutical, biological, and toxicological studies. Int J Nanomedicine. 10:5459–5473.
  • Elsenosy FM, Abdelbary GA, Elshafeey AH, Elsayed I, Fares AR. 2020. Brain targeting of duloxetine HCL via intranasal delivery of loaded cubosomal gel: in vitro characterization, ex vivo permeation, and in vivo biodistribution studies. Int J Nanomedicine. 15:9517–9537.
  • Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. 2005. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res. 22(12):2163–2173.
  • Fattorusso A, Matricardi S, Mencaroni E, Dell’Isola GB, Di Cara G, Striano P, Verrotti A. 2021. The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front Neurol. 12:674483.
  • Fazil M, Md S, Haque S, Kumar M, Baboota S, Kaur Sahni J, Ali J. 2012. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 47(1):6–15.
  • Fortuna A, Alves G, Serralheiro A, Sousa J, Falcão A. 2014. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules. Eur J Pharm Biopharm. 88(1):8–27.
  • Gaballa SA, El Garhy OH, Moharram H, Abdelkader H. 2020. Preparation and Evaluation of cubosomes/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res. 37(10):198.
  • Gagliardi A, Cosco D, Udongo BP, Dini L, Viglietto G, Paolino D. 2020. Design and characterization of glyceryl monooleate-nanostructures containing doxorubicin hydrochloride. Pharmaceutics. 12(11):1017.
  • Gangarossa G, Di Benedetto M, O'Sullivan GJ, Dunleavy M, Alcacer C, Bonito-Oliva A, Henshall DC, Waddington JL, Valjent E, Fisone G. 2011. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3. 1 expression in mouse dentate gyrus. PLoS One. 6(5):e19415.
  • Gao K, Jiang X. 2006. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Int J Pharm. 310(1-2):213–219.
  • Gieszinger P, Stefania Csaba N, Garcia-Fuentes M, Prasanna M, Gáspár R, Sztojkov-Ivanov A, Ducza E, Márki Á, Janáky T, Kecskeméti G, et al. 2020. Preparation and characterization of lamotrigine containing nanocapsules for nasal administration. Eur J Pharm Biopharm. 153:177–186.
  • Gindler EM, King JD. 1972. Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. Am J Clin Pathol. 58(4):376–382.
  • Gowthamarajan K, Singh SK. 2010. Dissolution testing for poorly soluble drugs: a continuing perspective. Dissolution Technol. 17(3):24–32.
  • Guinedi AS, Mortada ND, Mansour S, Hathout RM. 2005. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 306(1-2):71–82.
  • Gupta S, Samanta MK, Raichur AM. 2010. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPS PharmSciTech. 11(1):322–335.
  • Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. 1997. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir. 13(26):6964–6971.
  • Haque S, Md S, Fazil M, Kumar M, Sahni JK, Ali J, Baboota S. 2012. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation. Carbohydr Polym. 89(1):72–79.
  • Higuchi T. 1963. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52(12):1145–1149.
  • Himmerich H, Bartsch S, Hamer H, Mergl R, Schönherr J, Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U. 2014. Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3-and anti-Cd40-stimulated blood in vitro. Oxid Med Cell Longev. 2014:806162.
  • Hiragi T, Ikegaya Y, Koyama R. 2018. Microglia after seizures and in epilepsy. Cells. 7(4):26.
  • Holtman L, van Vliet EA, Aronica E, Wouters D, Wadman WJ, Gorter JA. 2013. Blood plasma inflammation markers during epileptogenesis in post–status epilepticus rat model for temporal lobe epilepsy. Epilepsia. 54(4):589–595.
  • Hurst S, Hoek J, Sheu S-S. 2017. Mitochondrial Ca2+ and regulation of the permeability transition pore. J Bioenerg Biomembr. 49(1):27–47.
  • Johnsson M, Barauskas J, Norlin A, Tiberg F. 2006. Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. J Nanosci Nanotechnol. 6(9-10):3017–3024.
  • Kassem AA, Salama A, Mohsen AM. 2022. Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: in vitro and in vivo assessments. J Drug Deliv Sci Technol. 68:103047.
  • Kaur P, Garg T, Rath G, Murthy RR, Goyal AK. 2016. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. 23(6):1912–1925.
  • Kaur S, Starr M. 1996. Motor effects of lamotrigine in naive and dopamine-depleted mice. Eur J Pharmacol. 304(1-3):1–6.
  • Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. 2001. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 54(5):356–361.
  • Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15(1):25–35.
  • Lara MG, Bentley MV, Collett JH. 2005. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm. 293(1-2):241–250.
  • Larsson K. 1989. Cubic lipid-water phases: structures and biomembrane aspects. J Phys Chem. 93(21):7304–7314.
  • Lee S-J. 2019. Effects of preconditioning exercise on nitric oxide and antioxidants in hippocampus of epileptic seizure. J Exerc Rehabil. 15(6):757–762.
  • Mohsen AM. 2019. Nanotechnology advanced strategies for the management of diabetes mellitus. Curr Drug Targets. 20(10):995–1007.
  • Mohsen AM. 2022. Cationic Polymeric Nanoparticles for Improved Ocular Delivery and Antimycotic Activity of Terconazole. J Pharm Sci. 111(2):458–468.
  • Murgia S, Bonacchi S, Falchi AM, Lampis S, Lippolis V, Meli V, Monduzzi M, Prodi L, Schmidt J, Talmon Y, et al. 2013. Drug-loaded fluorescent cubosomes: versatile nanoparticles for potential theranostic applications. Langmuir. 29(22):6673–6679.
  • Narashimhan B, Mallapragada S, Peppas N. 1999. Release kinetics, data interpretation. In: Mathiowitz E, editor. Encyclopedia of Controlled Drug Delivery. New York: John Wiley and Sons, Inc; p. 921.
  • Naresh RR, Pillai G, Udupa N, Chandrashekar G. 1994. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol. 26(1):46–48.
  • Nasr M, Ghorab MK, Abdelazem A. 2015. In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting. Acta Pharm Sin B. 5(1):79–88.
  • Ostadhadi S, Ahangari M, Nikoui V, Norouzi-Javidan A, Zolfaghari S, Jazaeri F, Chamanara M, Akbarian R, Dehpour A-R. 2016. Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test. Biomed Pharmacother. 82:713–721.
  • Palozza P, Muzzalupo R, Trombino S, Valdannini A, Picci N. 2006. Solubilization and stabilization of β-carotene in niosomes: delivery to cultured cells. Chem Phys Lipids. 139(1):32–42.
  • Patil RP, Pawara DD, Gudewar CS, Tekade AR. 2019. Nanostructured cubosomes in an in situ nasal gel system: an alternative approach for the controlled delivery of donepezil HCl to brain. J Liposome Res. 29(3):264–273.
  • Puig MV, Santana N, Celada P, Mengod G, Artigas F. 2004. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex. 14(12):1365–1375.
  • Rarokar NR, Saoji SD, Raut NA, Taksande JB, Khedekar PB, Dave VS. 2016. Nanostructured cubosomes in a thermoresponsive depot system: an alternative approach for the controlled delivery of docetaxel. AAPS PharmSciTech. 17(2):436–445.
  • Ritger PL, Peppas NA. 1987. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 5(1):37–42.
  • Rzajew J, Radzik T, Rebas E. 2020. Calcium-involved action of phytochemicals: carotenoids and monoterpenes in the brain. IJMS. 21(4):1428.
  • Salah S, Mahmoud AA, Kamel AO. 2017. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv. 24(1):846–856.
  • Salama AA, El-Kassaby M, Elhadidy ME, Raouf ERA, Abdalla AM, Farrag ARH. 2016. Effects of the Aqueous Seed Extract of Withania somnifera (Ashwagandha) against Pilocarpine-induced Convulsions in Rats. Int J Pharm Sci Rev Res. 41(1):116–121.
  • Salama A, Fayed HM, Elgohary R. 2021. L-carnitine alleviated acute lung injuries induced by potassium dichromate in rats: involvement of Nrf2/HO-1 signaling pathway. Heliyon. 7(6):e07207.
  • Salama A, Hegazy R, Hassan A. 2016. Intranasal chromium induces acute brain and lung injuries in rats: assessment of different potential hazardous effects of environmental and occupational exposure to chromium and introduction of a novel pharmacological and toxicological animal model. PLoS One. 11(12):e0168688.
  • Salama AH, Salama AA, Elhabak M. 2021. Single step nanospray drying preparation technique of gabapentin-loaded nanoparticles-mediated brain delivery for effective treatment of PTZ-induced seizures. Int J Pharm. 602:120604.
  • Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. 2021. Cubogel as potential platform for glaucoma management. Drug Deliv. 28(1):293–305.
  • Schiller Y, Krivoy N. 2009. Safety and efficacy of lamotrigine in older adults with epilepsy and co-morbid depressive symptoms. Clin Med Ther. 1CMT. :S2165.
  • Shah P, Dubey P, Vyas B, Kaul A, Mishra AK, Chopra D, Patel P. 2021. Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study. Artif Cells Nanomed Biotechnol. 49(1):511–522.
  • Shamma RN, Elsayed I. 2013. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res. 23(3):244–254.
  • Sherafudeen SP, Vasantha PV. 2015. Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharm Sci. 10(6):466–476.
  • Mohana Raghava Srivalli K, Lakshmi PK, Balasubramaniam J. 2013. Design of a novel bilayered gastric mucoadhesive system for localized and unidirectional release of lamotrigine. Saudi Pharm J. 21(1):45–52.
  • Suresh G, Yogesh N, Darshana B, Rashmi T, Milind U, Jayshree T. 2020. Development and evaluation of lamotrigine soya lecithin solid dispersion: in vitro and pharmacodynamic investigation. Int J App Pharm. 12(1):115–122.
  • Swamy N, Abbas Z. 2012. Mucoadhesive in situ gels as nasal drug delivery systems: an overview. Asian J Pharm Sci. 7(3):115–130.
  • Taymouri S, Varshosaz J. 2016. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res. 5:48.
  • Turski WA, Cavalheiro EA, Bortolotto ZA, Mello LM, Schwarz M, Turski L. 1984. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res. 321(2):237–253.
  • Williams MB, Jope RS. 1994. Protein synthesis inhibitors attenuate seizures induced in rats by lithium plus pilocarpine. Exp Neurol. 129(1):169–173.
  • Xu S, Sun Q, Fan J, Jiang Y, Yang W, Cui Y, Yu Z, Jiang H, Li B. 2019. Role of astrocytes in post-traumatic epilepsy. Front Neurol. 10:1149.
  • Ye JH, Hunt T, Wu W-H, McArdle JJ. 1997. Ondansetron modulates GABAA current of rat central nervous system neurons. Eur J Pharmacol. 337(1):87–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.